Skip to main content
. 2013 Oct 2;2013(10):CD003564. doi: 10.1002/14651858.CD003564.pub3
Study ID Beta‐agonist arm Placebo arm Correlation
Mean SD N Mean SD N  
Anderson 2001 Salb Disk 13.42 13.23 27 39.4 17.58 27 0.46
Anderson 2001 Salb MDI 8.51 13.75 27 39.4 17.58 27 0.46
Blake 1999 Salb 180 3.8 7.5 25 13.5 12.7 24  
Blake 1999 Salm 25 7.99 10.2 26 14.0 11.5 23  
Blake 1999 Salm 50 7.34 10.3 24 14.0 11.5 23  
Boner 1994 Form 12 2.2 8.3 15 14.5 13.4 15  
Bronski 1995 Salb MDI 16.0 11.0 44 23.0 20.0 44  
Bronski 1995 Salb Pwd 26.0 13.0 44 23.0 20.0 44  
Bronski 1999 Salm Disk 5.6 10.2 24 12.1 15.6 24  
Bronski 1999 Salm Diskhal 5.7 6.36 24 12.1 15.6 24  
Bronski 2002 Form 12 17.0 0.0 17 38.3 0.0 18  
Bronski 2002 Form 24 14.6 0.0 17 38.3 0.0 18  
Bronski 2002 Salb 8.6 0.0 17 37.1 0.0 18  
Carlsen 1995 Salm 25 19.0 16.7 23 30.0 16.7 23  
Carlsen 1995 Salm 50 18.0 14.3 23 30.0 16.7 23  
Cavagni 1993 Salb Jet 7.15 4.9 8 34.7 22.3 8  
Cavagni 1993 Salb MDI 15.9 9.3 9 28.9 21.8 9  
Clarke 1990 Fen ‐19.9 0.0 20 9.8 0.0 20  
Daugbjerg 1996 Form 12 11.0 0.0 16 35.0 0.0 16  
Debelic 1988 Reproterol 12.6 0.0 16 38.5 0.0 16  
DeBenedictis 1996 Salm 25 19.0 12.0 12 35.0 16.0 12 0.28
DeBenedictis 1996 Salm 50 15.0 13.0 12 35.0 16.0 12 0.33
DeBenedictis 1998 Salb 3.7 4.4 12 25.7 18.9 12  
Del Col 1993 Salb Jet 20.76 2.1 15 29.14 15.1 15  
Del Col 1993 Salb MDI 12.37 5.1 15 26.6 16.1 15  
Dinh Xuan 1989 Terb ‐2.24 17.7 10 35.2 22.1 10  
Egglestone 1981 Terb 250 10.0 8.24 17 32.0 16.49 17  
Ferrari 2000 Form 12 5.9 7.2 14 29.3 14.3 14  
Green 1992 Salm 50 3.2 4.8 13 26.6 10.27 13 0.30
Gronnerod 2000 Form 4.5 9.2 8.5 27 18.4 10.1 27  
Gronnerod 2000 Form 9 5.4 8.5 27 18.4 10.1 27  
Gronnerod 2000 Terb 500 3.3 10.2 27 18.4 10.1 27  
Hawksworth 2002 Salb HFA 15.4 9 23 33.7 8.3 24  
Hawksworth 2002 Salb MDI 14.9 9 24 33.7 8.3 24  
Henricksen 1983 Terb 26.0 22.4 14 37.0 14.9 14  
Henricksen 1992 Salb 18.0 17.3 12 44.0 13.8 12  
Henriksen 1992 Form 12 8.0 10.4 12 44.0 13.8 12  
Hills 1976 Salb ‐4.6 0.0 19 35.5 0.0 19  
Hills 1976 Salmefamol ‐2.6 0.0 19 35.5 0.0 19  
Kemp 1994 Salb 7.0 0.0 54 27.0 0.0 52  
Kemp 1994 Salm 42 13.0 0.0 53 27.0 0.0 52  
Konig 1981 Metaprot 19.0 12.0 24 36.0 15.0 24  
Konig 1984 Fen 0.4 4.3 10.1 12 27.8 14.9 12  
Konig 1984 Fen 0.8 2.5 13.0 12 27.8 14.9 12  
Larsson 1982 Fen ‐2.7 0.0 8 11.0 0.0 8  
McAlpine 1990 Form 12 7.7 8.6 11 32.7 16.5 11  
McFadden 1986 Salb (I) 1.1 0.0 15 10.8 0.0 15  
McFadden 1986 Salb (II) ‐1.1 0.0 20 14.1 0.0 20  
Morton 1989 Rimet 2.8 5.5 10 24.5 8.4 10  
Newnham 1993 Salb 200 3.8 18.2 11 27.1 15.9 11  
Newnham 1993 Salm 50 12.8 16.9 12 32.0 23.2 11  
Patel 1986 Salb 200 6.0 0.0 9 27.9 0.0 9  
Patel 1986 Tulob 200 9.7 0.0 9 27.9 0.0 9  
Patel 1986 Tulob 400 7.7 0.0 9 27.9 0.0 9  
Patessio 1991 Form 24 10.0 0.0 12 30.5 0.0 12  
Pearlman 2006 Form 12 7.6 0.0 22 13.2 0.0 20  
Pearlman 2006 Form 24 5.9 0.0 23 13.2 0.0 20  
Pearlman 2006 Salb 180 3.5 0.0 22 11.1 0.0 19  
Pearlman 2007 Salb 90 4.8 10.8 15 22.5 10.8 15 0.39
Philip 2007 Salm 50 10.7 8.1 46 21.8 8.1 46  
Richter 2002 Form 12 5.7 5.3 24 25.1 12.2 24  
Richter 2002 Salm 50 7.6 7.5 24 25.1 12.2 24  
Richter 2002 Terb 500 8.5 8.3 24 25.1 12.2 24  
Shapiro 2002 Form 12 12.4 14.6 19 32.9 16.8 17  
Shapiro 2002 Form 24 17.5 17.5 17 32.9 16.8 17  
Shapiro 2002 Salb 180 10.0 18.6 19 31.1 18.7 17  
Sturani 1983 Fen 400 15.8 7.9 12 36.0 6.9 12  
Sturani 1983 Salb 200 23.2 8.6 12 36.0 6.9 12  
VanHaitsma 2010 Salb 4.0 16.4 10 14.3 11.1 10  
Vasquez 1984 Salb 400 ‐0.3 4.9 13 14.3 9.8 12  
Walker 1986 Bitolterol 5.0 11.4 12 23.2 16.2 12  
Wolley 1990 Terb 500 17.0 6.9 12 34.0 13.8 12